Molecular Formula: | |
---|---|
Molecular Formula | C25H21FN2O |
Molecular Weight: | |
Molecular Weight | 384.45 |
COA: | |
COA | Inquire |
Targets: | |
Targets | Phosphodiesterase (PDE) |
Description: | |
Description | CP 461, belonging to a class of novel proapoptotic drugs with antineoplastic effect, specifically inhibit cyclic GMP phosphodiesterases but not cyclooxygenase-1 or -2. |
Purity: | |
---|---|
Purity | >98% |
Appearance: | |
Appearance | Solid powder |
Synonyms: | |
Synonyms | CP-461 free base; CP 461 free base; CP461 free base; N-benzyl-2-[(3Z)-6-fluoro-2-methyl-3-(pyridin-4-ylmethylidene)inden-1-yl]acetamide; UNII-824ZMS3BGL; OSI-461 free base |
MSDS: | |
MSDS | Inquire |
InChIKey: | |
---|---|
InChIKey | NVCAMOJXQVJSOM-XKZIYDEJSA-N |
InChI: | |
InChI | 1S/C25H21FN2O/c1-17-22(13-18-9-11-27-12-10-18)21-8-7-20(26)14-24(21)23(17)15-25(29)28-16-19-5-3-2-4-6-19/h2-14H,15-16H2,1H3,(H,28,29)/b22-13- |
Canonical SMILES: | |
Canonical SMILES | CC1=C(C2=C(C1=CC3=CC=NC=C3)C=CC(=C2)F)CC(=O)NCC4=CC=CC=C4 |